Enago Launches CLARA ― COVID-19 AI-Powered Tool for Researchers to Accelerate Scientific Breakthroughs & Create an Antidote to Coronavirus
As of April 20th, Coronavirus has adversely impacted 2.43 million humans directly; the silver-lining is how this unparalleled pandemic has brought together billions in our quest for the antidote to bring COVID-19 to a halt. Given the exponential volume of research in varied disciplines being generated at breakneck speed to find the solution to this unprecedented tragedy, it became imperative to gather these latest insights in one repository. Enago’s CLARA – COVID-19 Learning And Research Accelerator – will aid the researchers globally by collating the most relevant papers on Coronavirus research and clinical trials available in the public domain. Moreover, it’s extremely simple to use and discover material that is relevant to the search intention.
In these unprecedented circumstances, Enago’s AI engineers rapidly harnessed their efforts to ideate, create, & support an algorithm that singularly helps COVID-19 researchers by giving them round-the-clock access to 42,000+ papers & 650+ COVID-19 clinical trials from publishers. Holistically, CLARA spurs COVID-19 learning & research by organizing all the openly available data, discovering relevant research, and giving customized daily updates on clinical trials. Surely, CLARA couldn’t have been possible without the commitment displayed by the publishers such as Karger, Elsevier, Taylor & Francis, and many others who have made COVID-19 research open and free.
By providing fast & easy access to all the significant papers, CLARA is the much-needed catalyst that is primed to lead researchers towards a definite solution. Share this tool with fellow researchers to expedite our collective journey towards a cure for Coronavirus.
Link to CLARA portal: www.enago.com/covid
